Lumic AS is a company focused on the development and production of vaccination equipment for the fish farming industry both nationally and internationally.
Photo: Lumic
Seafood investment company Blue Future Holding has announced it has acquired a 51% stake in Lumic AS, a Norwegian company specialising in the development and production of vaccination equipment for the aquaculture sector.
The investment firm, which is growing its portfolio of aquaculture companies, also announced that one of its existing portfolio companies Greenfox Marine is now entering a "strategic partnership" with Lumic, developing an integrated health station for juvenile fish.
The collaboration will see Greenfox Marine's ultrasound and camera-based analysis technologies combined with Lumic's automated vaccination systems, to create a new solution capable of simultaneously analyzing fish internally and externally, vaccinating them, and sorting by gender, health condition, and size.
“This combination enables us to offer fish farmers a tool that increases survival rates and improves growth during the seawater phase. It’s a significant step towards more sustainable production,” said Hans-Magne Strømme, CEO of Lumic, in a press release.
Greenfox Marine says its ultrasound technology and algorithms can detect health risks such as heart function issues, kidney stones, and spinal deformities. “In addition to gender sorting, our technology evaluates relevant fish health and production parameters through individual monitoring of every fish being vaccinated," said Erling Aspen, CEO of Greenfox Marine.
"This can help optimize both juvenile production and the growth phase after transfer to seawater. We are currently adding a range of new diagnostic functions to our technology platforms,” Aspen added.
The first customer order for the integrated machine has already been received, with delivery expected in the second half of 2025, the companies said.
“Through this initiative, we can offer fish farmers a unique tool for deploying robust fish into the sea - with greater growth potential and lower mortality. This aligns perfectly with our investment strategy, which has sustainability and fish welfare as core values,” said Odd Magne Rødseth, CEO of Blue Future Holding.
Blue Future Holding now holds a controlling interest in both companies involved in the project, having acquired a 97% stake in Greenfox Marine in 2024, and now a 51% stake in Lumic.
In February, Blue Future Holdings acquired a majority stake in land-based aquaculture supplier Litus Akva, in a deal valued at NOK 50 million (EUR 4.3 million / USD 4.5 million).
Blue Future Holding's portfolio also includes 100% ownership of tilapia breeding specialist GenoMar Genetics Group, and aquaculture biotechnology firm Blue Analytics, in addition to a 10% stake in Icelandic land-based salmon farmer Laxey and 5% in land-based spotted wolffish farmer Aminor.
